![deepak Kulkarni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Deepak Kulkarni is currently working as a Director at Corium LLC.
Prior to this, he worked as a Managing Director at Webster Equity Partners, LLC from 2022 to 2023.
| Sociétés | Poste | Début |
|---|---|---|
Corium LLC
 Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Webster Equity Partners, LLC
 Webster Equity Partners, LLC Investment ManagersFinance Webster Equity Partners invests in middle market companies located in the United States with revenues of USD 20 - 200 million and EBITDA of USD 5 - 20 million. The firm focuses on a broad range of sectors. It participates in MBOs and growth capital transactions. The firm also acquires controlling interest. | Analyste en capital-investissement | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Webster Equity Partners, LLC
Webster Equity Partners, LLC Investment ManagersFinance Webster Equity Partners invests in middle market companies located in the United States with revenues of USD 20 - 200 million and EBITDA of USD 5 - 20 million. The firm focuses on a broad range of sectors. It participates in MBOs and growth capital transactions. The firm also acquires controlling interest. | Finance |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
